Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl)ation of proteins. Parp-2 deficiency in mice (Parp-2
process, as indicated by the short half-life of the ADPribose polymer, which is rapidly subjected to degradation by poly(ADP-ribose) glycohydrolase Yelamos et al., 2008) . Among the 17 members of the Parp family, Parp-1 (113 kDa) and Parp-2 (62 kDa) are so far the only Parp enzymes whose catalytic activity has been shown to be stimulated by DNA strand interruptions, targeting proteins mainly involved in chromatin structure and DNA metabolism Yelamos et al., 2008) . Whereas Parp-1-deficient (Parp-1 À/À ) mice develop spontaneous mammary and liver tumours with long latency and at a low incidence (Tong et al., 2002 (Tong et al., , 2007 , Parp-2 À/À mice do not show the propensity for development of spontaneous tumours (Menissier et al., 2003) . However, both Parp-1 À/À mice and Parp-2 À/À mice are very sensitive to ionizing radiation and alkylating agents, thus suggesting a role for these proteins in the cellular response to DNA damage and genomic stability through their physical association with, or by the poly(ADPribosyl)ation of their partner proteins (Menissier et al., 2003) . Indeed, inhibition of Parp activity is a potential therapeutic strategy for the treatment of cancers with specific DNA-repair defects (Bryant et al., 2005; Farmer et al., 2005) . In addition, stable depletion of Parp-1 reduces in vivo melanoma growth and increases chemosensitivity, providing novel evidence for a direct role of Parp-1 in tumour aggressiveness and chemoresistance (Tentori et al., 2008) . Accordingly, clinical trials in cancer using unspecific Parp inhibitors, targeting the highly conserved catalytic domain of Parp family members, are now ongoing (Yelamos et al., 2008; Fong et al., 2009) . However, Parp-1 and Parp-2 have different targets both in DNA and in proteins, suggesting that they might have specific biological functions (Yelamos et al., 2008) . Indeed, we have previously shown that the genetic disruption of Parp-2, but not of Parp-1, in mice affects various differentiation processes, including spermatogenesis , adipogenesis (Bai et al., 2007) and survival of thymocytes indicating, in the later case, a crucial role of Parp-2 in mediating T-cell survival during thymopoiesis (Yelamos et al., 2006) . T-cell development and homeostasis of thymocytes is ordered by sequential steps involving cell proliferation and apoptosis. After arriving as precursors from the bone marrow, highly immature CD4 À
CD8
À doublenegative thymocytes undergo extensive V(D)J recombination of T-cell receptor-b (TCRb) genes initiated by the lymphocyte-specific Rag1 and Rag2 endonucleases. A successfully rearranged and expressed TCRb associates with the pre-TCR and CD3 chains to form the pre-TCR complex (von Boehmer and Fehling, 1997) . Consequences of pre-TCR signalling include proliferation and phenotypic alteration to yield CD4 þ CD8 þ doublepositive (DP) thymocytes, the most abundant population in thymus (von Boehmer et al., 1999) . DP thymocytes undergo Rag-mediated multiple rounds of TCRa gene rearrangements that maximise the chances of forming a functional ab TCR complex (Petrie et al., 1993; Hawwari et al., 2005) . DP thymocytes expressing ab TCR rescued through positive selection finally differentiate into either CD4 þ or CD8 þ single-positive thymocytes, which then will seed the peripheral lymphoid tissues (Werlen et al., 2003) .
Despite continuous exposure to DNA double-strand breaks (DSBs) generated by endonucleases Rag1 and Rag2 during initiation of the V(D)J recombination events and from proliferative bursts, thymocytes efficiently escape transformation. V(D)J recombination is tightly coupled to the recruitment of the non-homologous end-joining (NHEJ) repair machinery to repair DNA damage and avoid tumour development Lee et al., 2004) . Another distinct DNArepair pathway, termed homologous recombination (HR), is critical for resolving DSBs during meiotic recombination (Paques and Haber, 1999) and in proliferating cells (Sonoda et al., 1998) . Accordingly, loss of either NHEJ or HR leads to accumulation of DSBs, resulting in the activation of p53-dependent apoptotic and cell-cycle checkpoint pathways to avoid tumour development (Riley et al., 2008) . The involvement of Parp-2 in DSBs repair mediated by either HR or NHEJ and its functional interaction with p53 still remain to be determined. Previously, we have shown that Parp-2 deficiency leads to an important decrease in the number of thymocytes (50% reduction compared with that in wild-type mice) associated with decreased DP cell survival, suggesting that Parp-2 plays an important role in T-cell survival during thymopoiesis by mechanisms that could prevent the activation of DNA damage-dependent apoptotic response during TCR gene rearrangements (Yelamos et al., 2006) .
To determine whether there is a link between Parp-2 and the p53 DNA damage-dependent apoptotic response, Parp-2 À/À mice were crossed with p53 À/À mice, and the resulting Parp-2 þ /À p53 þ /À mice were intercrossed to generate all possible combinations of Parp-2 and p53 targeted alleles. To enrich for embryos with double null alleles, we also intercrossed Parp-2
þ /À female mice. All mice used in this study were in a C57BL/6J background and were maintained in a rodent barrier facility to guarantee the specific pathogen-free health status. For both crosses, we observed a significantly reduced number of Parp-2
À/À pups as compared with the expected Mendelian frequency (Supplementary Figure S1 ) consistent with embryonic lethality of the double null mice. The other genotypes were obtained at approximately expected Mendelian frequency (data not shown). By contrast, no embryonic lethality has been reported for the Parp-1
À/À mice (Conde et al., 2001; Tong et al., 2001) . These data suggest a specific interaction between the Parp-2 and p53-dependent pathways that affect embryonic development. To determine at which stage the double Parp-2/p53-null embryos died during development, we performed a timed-mating study by crossing Parp-2
females. This timed-mating study showed that the expected percentage of Parp-2 À/À p53 À/À embryos survived at embryonic day 13.5 (Supplementary Figure S1 ), indicating that lethality of Parp-2/p53 double-null embryos takes place at a late development stage. A complex mechanism underlying this embryonic mortality might be expected from the fact that both p53 and Parp-2 could influence in this condition. We also found that Parp-2 À/À p53 À/À males were able to produce progeny, whereas Parp-2
females were not (data not shown).
Thymocytes were examined in 6-week-old Parp-2/p53 double-null mice and compared to those of their wild-type, Parp-2 and p53 single-null littermates. We observed reduced thymic cellularity in Parp-2 À/À mice that were completely restored in a p53-deficient background at the level of wild-type control mice, and p53 À/À mice, which at this age have a similar number of thymocytes as wild-type mice ( Figure 1a ). These data show that additional removal of p53 rescues the defects in thymocyte development observed in Parp-2 À/À and strongly establishes the activation of p53-checkpoint pathways as the cause for the high susceptibility of Parp-2 À/À thymocytes to apoptosis. Thymocyte subsets were analysed by flow cytometry using antibodies specific for CD4 and CD8 T-cell surface antigens. Figure 1b shows similar distribution of thymocytes among DP and SP compartments in the four genotypes. Only the percentage of DN thymocytes was slightly increased in Parp-2 À/À mice as compared with that in the Parp-2/p53 double-null, Parp-2 þ / þ p53 À/À and wild-type littermates, as previously described (Yelamos et al., 2006) .
We next studied whether Parp-2 deficiency induces the accumulation of DNA damage in thymocytes from 6-weeks-old mice by immunostaining for phosphorylation of histone H2AX (g-H2AX), as an indicator of DSBs (Rogakou et al., 1998; Chen et al., 2000) . Parp-2 deficiency induced marked accumulation of g-H2AX foci in thymocytes independently of the p53 background, with about 60% of the cells with at least one foci of g-H2AX, whereas in Parp-2
À/À thymocytes only about 35% of the cells are positive for g-H2AX (Figures 2a and b) . In addition, whereas few Parp-2
À/À g-H2AX-positive thymocytes had multiple g-H2AX foci (around 5% of g-H2AX-positive cells with more than three g-H2AX foci), Parp-2-deficient thymocytes had multiple g-H2AX foci (16% of g-H2AX-positive cells) and cells with diffuse g-H2AX staining (12% of g-H2AX-positive cells) (Figures 2c and d) . The increased level of g-H2AX in Parp-2 À/À thymocytes as compared with that in cells expressing Parp-2 was also confirmed by western blotting (Figures 2e and f) . This finding supports the hypothesis that in the T-cell lineage, Parp-2 acts as a caretaker maintaining genetic stability. Altogether, these data suggest an important role of Parp-2 in the resolution of DSBs generated during V(D)J recombination of the TCR genes and/or during rapid expansion of thymocytes (replication-associated DSBs), by mechanisms that could involve chromatin remodelling and accessibility and/or DNA-repair pathways. Whether Parp-2 has a role in DSB-repair pathways is an open question. An involvement of Parp-2 in DSB repair has been proposed previously on the basis of the increased radiation sensitivity of Parp-2-deficient cells (Menissier et al., 2003) . In addition, double deletion of Parp-2 and Atm, an early signalling molecule that initiates the transduction cascade at DSB sites (Shiloh, 2003) , is synthetically lethal in mice (Huber et al., 2004) , suggesting that Parp-2 and Atm may participate in overlapping DNA damage signalling pathways or regulate distinct forms of DNA repair that partially compensate for each other.
The high accumulation of DSBs in Parp-2-deficient thymocytes suggests a possible increased susceptibility to oncogenesis. However, previous data (Menissier et al., 2003) did not show any increased susceptibility to spontaneous tumours in Parp-2 À/À mice. To test potential cooperation between Parp-2 and p53 in tumorigenesis, we assessed the spontaneous rate of tumour development in Parp-2 þ / þ , Parp-2 þ /À and Parp-2 À/À mice in a p53-null background for 300 days.
Comparison of Kaplan-Meier tumour-free survival curves showed that loss of both alleles of Parp-2 significantly accelerated the spontaneous tumour development of p53 À/À mice (Figure 3a) . The median time to death in Parp-2
À/À mice was 109 days compared with a median time of 155 days in Parp-2 þ / þ p53 À/À mice (Po0.001). However, loss of only one allele of Parp-2 did not accelerate the tumour onset in p53 À/À mice (median time to death of 153 days) (Figure 3a) . These data suggest a synergistic interaction between Parp-2 and p53 in the maintenance of genome integrity, resulting in accelerated tumorigenesis when both genes are disrupted in mice (Figure 3b ). Parp-1 deficiency has also been shown to shorten the latency of tumour development in p53 À/À mice (Beneke and Mo¨ro¨y, 2001; Tong et al., 2001 Tong et al., , 2003 Tong et al., , 2007 . However, Parp-1 deficiency in mice, in contrast to Parp-2 deficiency, did not affect either thymocyte development (Yelamos et al., 2006) or thymocyte apoptosis in response to different stimuli (Wang et al., 1997) .
Immunohistopathological analysis of tumours from our Parp-2
À/À mice showed that more than 90% of neoplastic lesions belonged to T-cell lymphoma as determined by CD3 positivity as a marker of T-cells and Pax-5 negativity as a marker of B-cells (Table 1 and data not shown). As shown in Table 1 , the tumour À/À mice in a C57BL/6J background (Jackson Laboratory, Bar Harbor, ME, USA) to generate Parp-2 þ /À p53 þ /À mice, which were then bred to generate all cohort mice. In addition, Parp-2 þ /À p53 À/À males was also intercrossed with Parp-2 þ /À p53 þ /À female mice. The mice were genotyped for p53 by PCR using the following primers: IMR0013: 5 0 -CTTGGGTGGAG AGGCTATTC-3 0 ; IMR0014: 5 0 -AGGTGAGATGACAGGAGA TC-3 0 ; IMR0336: 5 0 -ATAGGTCGGCGGTTCAT-3 0 ; IMR0337: 5 0 -CCCGAGTATCTGGAAGACAG-3 0 . Parp-2 genotyping was performed as described by Yelamos et al. (2006) . All animals were bred and maintained under specific pathogen-free conditions in a barrier area. (a) Thymocytes numbers from 6-week-old Parp-2
The values represent the mean±s.d.; *Po0.05 determined by Student's t-test statistical analysis. (b) A representative dot plot showing CD4 and CD8 expression on total thymocytes by flow cytometry. Cell suspensions were washed in phosphate-buffered saline, resuspended in phosphate-buffered saline containing 0.5% bovine serum albumin and incubated with phycoerythrin-conjugated rat anti-mouse CD4 (GK1.5) and fluorescein isothiocyanate-conjugated rat anti-mouse CD8 (53-6.7) antibodies (Pharmingen, San Diego, CA, USA) on ice for 30 min. All cell analysis was performed with a FACS Calibur cytometer and the CellQuest software (BD, San Jose, CA, USA). The percentage of cells in each quadrant is indicated and represents the mean from at least eleven mice in each group. Parp, poly(ADPribose) polymerase. 
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thymocytes. For immunofluorescence staining, thymocytes were deposited onto poly-lysine-precoated coverslips and fixed with 2% paraformaldehyde, followed by incubation with a primary mouse monoclonal antibody against g-H2AX (Millipore, Billerica, MA, USA) and secondary Alexa Fluor-488 F(ab) 2 fragment goat anti-mouse antibody (Invitrogen, Carlsbad, CA, USA). The coverslips were sealed with mounting medium containing DAPI (4 0 ,6 0 -diamidino-2-phenylindole) and microscopy was performed by using an Olympus BX61 microscope. .05 determined by Student's t-test statistical analysis (e) A representative western blot of g-H2AX and H2AX protein expression. Phosphate-buffered saline-washed thymocytes were homogenized in 0.2 N H 2 SO 4 and centrifuged at 13 000 Â g. Histones were pelleted from the supernatant by adding 0.25 volumes of 100% ethanol (w/v) trichloroacetic acid. The pellets were re-suspended in 100% ethanol overnight and centrifuged again at 13 000 Â g. The pellets were dissolved in water and evaluated for protein concentration (Bio-Rad Laboratories, Mu¨nchen, Germany). An aliquot corresponding to 15 mg of protein was loaded with Laemmli buffer (Sigma-Aldrich, St Louis, MO, USA) into each lane before separation on 15% sodium dodecyl sulphate-polyacrylamide gel electrophoresis gel and transferred to a nitrocellulose membrane. Membranes blocked in 5% non-fat dry milk in Tris-buffered saline/0.05% Tween-20 (Sigma-Aldrich) overnight at 4 1C, rinsed and incubated with anti-g-H2AX monoclonal antibody (Millipore) overnight. Rabbit anti-H2AX polyclonal antibody (Abcam, Cambridge, UK) was used as loading control. Binding of primary antibodies was shown using horseradish peroxidase-coupled secondary antibodies (Promega, Madison, WI, USA). Signals were developed using an enhanced chemiluminiscence kit (AmershamPharmacia Biotech, Buckinghamshire, UK), according to the manufacturer's instructions. (f) Densitometry analysis (optical density) of g-H2AX bands from western blotting. The results are expressed as mean±s.e.m.; *Po0.05 determined by Student's t-test statistical analysis. The data are from four mice from each genotype. DSB, double-strand break; Parp, poly(ADP-ribose) polymerase.
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Tumours, others than T-cell lymphomas, were observed at largely reduced frequency in our mutant mice models (Table 1 ). In addition, we measured the mitotic index (mean number of mitosis in 10 consecutive high-power ( Â 400) fields) and the proliferation index (measured as the level of expression of nuclear Ki67 protein) in spontaneous tumours from Parp-2 þ / þ p53 À/À and Parp-2
mice, as indicative of tumour aggressiveness. A similar percentage of Ki67-positive cells were found in tumours from Parp-2
and Parp-2
mice, whereas a slight, not statistically significant, increase in the mitotic index was found in tumours from Parp-2
À/À mice as compared with those from Parp-2 Figure S2) . Altogether, these data indicate that Parp-2 deficiency shortens the spontaneous tumour latency in p53 À/À mice without modifying either the tumour spectrum or the aggressiveness properties of the tumours developed in p53-deficient mice.
In agreement with previous studies (Menissier et al., 2003) , we did not observe spontaneous tumour formation in our Parp-2-deficient mice, despite this mutant mice presenting a level of DSB accumulation similar as that in Parp-2
À/À mice (Figure 2 ). Our data indicate that activation of p53-checkpoint controls is sufficient to prevent tumour development in Parp-2-mutant mice by inducing apoptosis of cells with persistent DSBs (Figure 3b) . Similarly, both NHEJdeficient and HR-deficient mice do not usually develop early tumours in spite of DSB accumulation. However, removal of p53 in these mutant mice models leads to massive genomic instability and they have increased susceptibility to malignant transformation (Hakem, 2008) . Similar to Parp-2-deficient mice, removal of p53 
Percent tumour-free survival is plotted as a function of time in days. The difference in survival between Parp-2 þ / þ p53 À/À and Parp-2 À/À p53 À/À mice was highly significant (Po0.001) as determined by log-rank test. Note that during the time of the study (300 days), no Parp-2 À/À p53 þ / þ mice developed tumour. The insert indicates the median time to death of mice from each genotype. (b) A proposed model depicting the accumulation of DNA DSBs in Parp-2 À/À thymocytes during thymocyte development and the outcomes in the presence or absence of p53. DSB, double-strand break; Parp, poly(ADP-ribose) polymerase.
Interplay of Parp-2 and p53 in tumorigenesis L Nicolás et al completely restored the survival and development of thymocytes in mice with a T-cell-specific disruption of Brca1, a component of the HR pathway, although the surviving T-cells harbour extensive chromosomal alterations and have increased susceptibility to malignant Tcell transformation (Mak et al., 2000) . By contrast, inactivation of p53 in NHEJ-deficient mice does not restore T-lymphocyte development, but these mice develop early pro-B-cell lymphomas with chromosomal translocation at chromosome-12 at the immunoglobulin locus and chromosome-15 near the proto-oncogene cMyc Frank et al., 2000; Gao et al., 2000; Rooney et al., 2004) . Recently, Robert et al. (2009) À/À p53 À/À mice succumb to thymic lymphoma rather than B-cell lymphomas. In agreement with those authors, our data also suggest that thymocytes may show higher levels of spontaneous DNA damage, posses a lower intrinsic threshold for malignant transformation, or reside in a niche that supports rapid expansion of cancerous cells, as compared with cells in other tissues (Bassing et al., 2008) .
In summary, our findings show that Parp-2-deficient thymocytes harbour substantial accumulation of DSBs that are likely sensed and eliminated by a p53-dependent checkpoint pathway. Further understanding of how Parp-2 coordinates, repair, signalling and surveillance functions in response to intrinsic DNA damage during thymocyte development will provide further insights into the mechanisms underlying malignant transformation disorders. As loss of Parp-2 and p53 do not appear to be functionally equivalent, DNA damage is p53-independent whereas apoptosis is p53-dependent (Xu et al., 2008) , and their simultaneous loss substantially accelerates tumorigenesis, our work highlights the potential importance of examining human tumours for the status of both genes. Interplay of Parp-2 and p53 in tumorigenesis L Nicolás et al
